Human concentrative nucleoside transporter 1-mediated uptake of 5-azacytidine enhances DNA demethylation

Molecular Cancer Therapeutics
Maria RiusFrank Lyko

Abstract

The DNA methyltransferase inhibitors 5-azacytidine (5-azaCyd) and 5-aza-2'-deoxycytidine have found increasing use for the treatment of myeloid leukemias and solid tumors. Both nucleoside analogues must be transported into cells and phosphorylated before they can be incorporated into DNA and inactivate DNA methyltransferases. The members of the human equilibrative and concentrative nucleoside transporter families mediate transport of natural nucleosides and some nucleoside analogues into cells. However, the molecular identity of the transport proteins responsible for mediating the uptake of 5-azanucleosides has remained unknown. To this end, we have generated a stably transfected Madin-Darby canine kidney strain II cell line expressing recombinant hCNT1. An antiserum directed against hCNT1 specifically detected the protein in the apical membrane of hCNT1-expressing Madin-Darby canine kidney cells. Using [14C]5-azaCyd, we show here that hCNT1 mediated the Na+-dependent uptake of this drug with a Km value of 63 micromol/L. Na+-dependent transport of radiolabeled cytidine, uridine, and 5-fluoro-5'-deoxyuridine further showed the functionality of the transporter. hCNT1-expressing cells were significantly more sensitive to 5-azaCyd,...Continue Reading

References

Apr 1, 1977·Journal of Medicinal Chemistry·K K ChanW Sadée
Jun 24, 1983·Biochimica Et Biophysica Acta·M A Gama-SosaM Ehrlich
Apr 9, 2001·American Journal of Physiology. Renal Physiology·L M MangraviteK M Giacomini
Jun 9, 2001·Molecular Membrane Biology·M Pastor-AngladaM Molina
Jan 16, 2003·Nucleic Acids Research·Dirk StachFrank Lyko
Jul 3, 2003·Pflügers Archiv : European journal of physiology·Stephen A BaldwinJames D Young
Jul 12, 2003·Pflügers Archiv : European journal of physiology·Jennifer H GrayKathleen M Giacomini
May 28, 2004·Nature·Gerda EggerPeter A Jones
Jan 15, 2005·Virus Research·Marçal Pastor-AngladaF Javier Casado
Dec 13, 2005·Nature Clinical Practice. Oncology·Lewis R Silverman, Ghulam J Mufti
Mar 3, 2006·Cancer Research·Carlo StresemannFrank Lyko
Sep 12, 2006·Proceedings of the National Academy of Sciences of the United States of America·Gerda EggerGangning Liang
Mar 9, 2007·Cancer Metastasis Reviews·Jing ZhangCarol E Cass
Jun 6, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kilian BartholoméDietrich Keppler
Oct 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kim AppletonRobert Brown
Apr 22, 2008·International Journal of Cancer. Journal International Du Cancer·Carlo Stresemann, Frank Lyko
Sep 16, 2008·Molecular Cancer Therapeutics·Carlo StresemannFrank Lyko

❮ Previous
Next ❯

Citations

Dec 20, 2011·Oncogene·M Rius, F Lyko
Feb 24, 2012·Nucleosides, Nucleotides & Nucleic Acids·Vijaya L DamarajuZeen Tong
Sep 26, 2009·Blood·Keith D Robertson, Kapil N Bhalla
May 28, 2010·Pharmacogenomics·Ekaitz Errasti-Murugarren, Marçal Pastor-Anglada
Aug 22, 2015·Expert Review of Anticancer Therapy·Abdallah Abou ZahrAmer M Zeidan
Jul 2, 2010·Pharmaceuticals·Paul M HowellHung T Khong
Jan 9, 2015·Drug Metabolism Reviews·Lisa Pleyer, Richard Greil
Dec 26, 2013·Experimental Hematology·Piyanuch SripayapKeiya Ozawa
Mar 20, 2012·Cancer Letters·Sau Wai HungRajgopal Govindarajan
Sep 18, 2010·Trends in Pharmacological Sciences·Xiaojing YangPeter A Jones
Sep 11, 2014·Pharmacology & Therapeutics·Ioannis AnestopoulosMihalis I Panayiotidis
Apr 13, 2011·Genes, Chromosomes & Cancer·Laia Simó-RiudalbasManel Esteller
Apr 12, 2016·Clinical Pharmacology and Therapeutics·P FiselM Schwab
Mar 25, 2011·Biochemical Society Transactions·Gayle MarshallSylvie M Guichard
Jul 26, 2013·Epigenetics : Official Journal of the DNA Methylation Society·Miguel Vizoso, Manel Esteller
Jul 9, 2013·Cancer Treatment Reviews·Pasano Bojang, Kenneth S Ramos
Feb 26, 2015·Frontiers in Pharmacology·Marçal Pastor-Anglada, Sandra Pérez-Torras
Jun 23, 2016·Clinical Epigenetics·Jeannine DieschKatharina S Götze
Oct 22, 2016·Advanced Pharmaceutical Bulletin·Farhad JahanfarHamed Hamishehkar
Aug 10, 2011·Molecular Pharmacology·Ekaitz Errasti-MurugarrenMarçal Pastor-Anglada
Feb 16, 2019·Current Molecular Pharmacology·Jasmine KaurScott T Eblen
Jan 3, 2014·The Journal of Clinical Investigation·Marianne B TreppendahlKirsten Grønbæk
Feb 25, 2011·Cellular Signalling·Juan RenShi-Wen Jiang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.